Mort par excès de travail : Questions médicales fréquentes
Nom anglais: Karoshi Death
Descriptor UI:D065907
Tree Number:C23.550.260.322.250.500
Termes MeSH sélectionnés :
Staphylococcus aureus
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Mort par excès de travail : Questions médicales les plus fréquentes",
"headline": "Mort par excès de travail : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Mort par excès de travail : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-14",
"dateModified": "2025-02-08",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Mort par excès de travail"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Mort subite cardiaque",
"url": "https://questionsmedicales.fr/mesh/D016757",
"about": {
"@type": "MedicalCondition",
"name": "Mort subite cardiaque",
"code": {
"@type": "MedicalCode",
"code": "D016757",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.260.322.250"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Mort par excès de travail",
"alternateName": "Karoshi Death",
"code": {
"@type": "MedicalCode",
"code": "D065907",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Ariane Lewis",
"url": "https://questionsmedicales.fr/author/Ariane%20Lewis",
"affiliation": {
"@type": "Organization",
"name": "NYU Langone Medical Center, New York, New York."
}
},
{
"@type": "Person",
"name": "David M Greer",
"url": "https://questionsmedicales.fr/author/David%20M%20Greer",
"affiliation": {
"@type": "Organization",
"name": "Boston University School of Medicine, Boston, Massachusetts."
}
},
{
"@type": "Person",
"name": "Gene Sung",
"url": "https://questionsmedicales.fr/author/Gene%20Sung",
"affiliation": {
"@type": "Organization",
"name": "University of Southern California, Los Angeles."
}
},
{
"@type": "Person",
"name": "Ning Xiao",
"url": "https://questionsmedicales.fr/author/Ning%20Xiao",
"affiliation": {
"@type": "Organization",
"name": "School of Forensic Medicine, Southern Medical University, Guangzhou, Guangdong, China (mainland)."
}
},
{
"@type": "Person",
"name": "Yan-Geng Yu",
"url": "https://questionsmedicales.fr/author/Yan-Geng%20Yu",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Forensic Pathology, Ministry of Public Security, Guangzhou, Guangdong, China (mainland)."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Staphylococcus aureus vaccine strategy: Promise and challenges.",
"datePublished": "2023-03-13",
"url": "https://questionsmedicales.fr/article/36958134",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.micres.2023.127362"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluation of Omadacycline Alone and in Combination with Rifampin against Staphylococcus aureus and Staphylococcus epidermidis in an",
"datePublished": "2023-05-24",
"url": "https://questionsmedicales.fr/article/37222591",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1128/aac.01317-22"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Staphylococcus aureus-antagonizing human nasal commensal Staphylococcus lugdunensis depends on siderophore piracy.",
"datePublished": "2024-10-22",
"url": "https://questionsmedicales.fr/article/39438987",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s40168-024-01913-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Dynamics of a Staphylococcus aureus infective endocarditis simulation model.",
"datePublished": "2022-05-27",
"url": "https://questionsmedicales.fr/article/35460117",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/apm.13231"
}
},
{
"@type": "ScholarlyArticle",
"name": "Antimicrobial Resistance Patterns of Outpatient Staphylococcus aureus Isolates.",
"datePublished": "2024-06-03",
"url": "https://questionsmedicales.fr/article/38874923",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1001/jamanetworkopen.2024.17199"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "États, signes et symptômes pathologiques",
"item": "https://questionsmedicales.fr/mesh/D013568"
},
{
"@type": "ListItem",
"position": 3,
"name": "Processus pathologiques",
"item": "https://questionsmedicales.fr/mesh/D010335"
},
{
"@type": "ListItem",
"position": 4,
"name": "Mort",
"item": "https://questionsmedicales.fr/mesh/D003643"
},
{
"@type": "ListItem",
"position": 5,
"name": "Mort subite",
"item": "https://questionsmedicales.fr/mesh/D003645"
},
{
"@type": "ListItem",
"position": 6,
"name": "Mort subite cardiaque",
"item": "https://questionsmedicales.fr/mesh/D016757"
},
{
"@type": "ListItem",
"position": 7,
"name": "Mort par excès de travail",
"item": "https://questionsmedicales.fr/mesh/D065907"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Mort par excès de travail - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Mort par excès de travail",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-05",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Mort par excès de travail",
"description": "Comment diagnostiquer le Karoshi ?\nQuels examens sont nécessaires ?\nQuels signes indiquent un risque de Karoshi ?\nLe Karoshi est-il reconnu médicalement ?\nComment évaluer le stress au travail ?",
"url": "https://questionsmedicales.fr/mesh/D065907?mesh_terms=Staphylococcus+aureus&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Mort par excès de travail",
"description": "Quels sont les symptômes du Karoshi ?\nLe Karoshi cause-t-il des problèmes cardiaques ?\nY a-t-il des symptômes psychologiques ?\nComment le stress affecte-t-il le corps ?\nLes symptômes varient-ils selon les individus ?",
"url": "https://questionsmedicales.fr/mesh/D065907?mesh_terms=Staphylococcus+aureus&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Mort par excès de travail",
"description": "Comment prévenir le Karoshi ?\nLe temps de repos est-il important ?\nLes entreprises peuvent-elles aider ?\nDes programmes de bien-être existent-ils ?\nL'éducation sur le stress est-elle utile ?",
"url": "https://questionsmedicales.fr/mesh/D065907?mesh_terms=Staphylococcus+aureus&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Mort par excès de travail",
"description": "Quels traitements sont disponibles pour le Karoshi ?\nLa médication est-elle nécessaire ?\nComment la thérapie aide-t-elle ?\nLes changements de mode de vie sont-ils efficaces ?\nLe soutien social joue-t-il un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D065907?mesh_terms=Staphylococcus+aureus&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Mort par excès de travail",
"description": "Quelles complications peuvent survenir ?\nLe Karoshi peut-il entraîner des incapacités ?\nY a-t-il des effets à long terme ?\nLe Karoshi affecte-t-il la qualité de vie ?\nLes complications sont-elles réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D065907?mesh_terms=Staphylococcus+aureus&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Mort par excès de travail",
"description": "Quels sont les principaux facteurs de risque ?\nLe manque de soutien social est-il un risque ?\nLes exigences professionnelles influencent-elles ?\nLe type de travail joue-t-il un rôle ?\nL'âge est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D065907?mesh_terms=Staphylococcus+aureus&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer le Karoshi ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique de travail, les symptômes et l'exclusion d'autres causes."
}
},
{
"@type": "Question",
"name": "Quels examens sont nécessaires ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens médicaux comme des analyses sanguines et des tests cardiaques peuvent être effectués."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un risque de Karoshi ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue extrême, troubles du sommeil, et symptômes cardiovasculaires sont des indicateurs."
}
},
{
"@type": "Question",
"name": "Le Karoshi est-il reconnu médicalement ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est reconnu comme une cause de décès liée au travail dans certains pays."
}
},
{
"@type": "Question",
"name": "Comment évaluer le stress au travail ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des questionnaires et des évaluations psychologiques peuvent aider à mesurer le stress."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes du Karoshi ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, douleurs thoraciques, et troubles mentaux comme l'anxiété."
}
},
{
"@type": "Question",
"name": "Le Karoshi cause-t-il des problèmes cardiaques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut entraîner des maladies cardiaques et des AVC."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes psychologiques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, dépression, irritabilité et troubles de la concentration sont fréquents."
}
},
{
"@type": "Question",
"name": "Comment le stress affecte-t-il le corps ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress prolongé peut provoquer des troubles métaboliques et des douleurs physiques."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon les individus ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de la résilience individuelle et des facteurs de stress."
}
},
{
"@type": "Question",
"name": "Comment prévenir le Karoshi ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Équilibrer le travail et la vie personnelle, et gérer le stress sont essentiels."
}
},
{
"@type": "Question",
"name": "Le temps de repos est-il important ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, prendre des pauses régulières et des congés est crucial pour la santé mentale."
}
},
{
"@type": "Question",
"name": "Les entreprises peuvent-elles aider ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en promouvant un environnement de travail sain et en limitant les heures supplémentaires."
}
},
{
"@type": "Question",
"name": "Des programmes de bien-être existent-ils ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreuses entreprises offrent des programmes de bien-être pour leurs employés."
}
},
{
"@type": "Question",
"name": "L'éducation sur le stress est-elle utile ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sensibiliser les employés aux risques du stress peut aider à prévenir le Karoshi."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour le Karoshi ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut la thérapie, la gestion du stress et des changements de mode de vie."
}
},
{
"@type": "Question",
"name": "La médication est-elle nécessaire ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Parfois, des antidépresseurs ou anxiolytiques peuvent être prescrits pour soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Comment la thérapie aide-t-elle ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie aide à gérer le stress, à améliorer la santé mentale et à développer des stratégies d'adaptation."
}
},
{
"@type": "Question",
"name": "Les changements de mode de vie sont-ils efficaces ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, adopter un mode de vie équilibré, avec du repos et de l'exercice, est crucial."
}
},
{
"@type": "Question",
"name": "Le soutien social joue-t-il un rôle ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le soutien des amis et de la famille est essentiel pour la récupération."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des maladies cardiovasculaires, des troubles mentaux et des AVC."
}
},
{
"@type": "Question",
"name": "Le Karoshi peut-il entraîner des incapacités ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des problèmes de santé chroniques peuvent entraîner des incapacités à long terme."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets à long terme ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut avoir des effets durables sur la santé physique et mentale."
}
},
{
"@type": "Question",
"name": "Le Karoshi affecte-t-il la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut réduire significativement la qualité de vie et le bien-être général."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié et des changements de mode de vie."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les heures de travail excessives, le stress élevé et un mode de vie sédentaire sont des facteurs clés."
}
},
{
"@type": "Question",
"name": "Le manque de soutien social est-il un risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'isolement social peut augmenter le risque de Karoshi et de problèmes de santé."
}
},
{
"@type": "Question",
"name": "Les exigences professionnelles influencent-elles ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des exigences professionnelles élevées et des délais serrés augmentent le stress."
}
},
{
"@type": "Question",
"name": "Le type de travail joue-t-il un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les emplois à haute pression, comme ceux dans la finance, sont plus à risque."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les travailleurs plus âgés peuvent être plus vulnérables aux effets du stress au travail."
}
}
]
}
]
}
Staphylococcus aureus (S. aureus) is a leading and crucial infectious threat to global public health due to the widespread emergence of antibiotic-resistant strains such as Methicillin-Resistant S. au...
Bacterial pathogens such as Staphylococcus aureus colonize body surfaces of part of the human population, which represents a critical risk factor for skin disorders and invasive infections. However, s...
We could cultivate S. lugdunensis from the noses of 6.3% of healthy human volunteers. In addition, S. lugdunensis DNA could be identified in metagenomes of many culture-negative nasal samples indicati...
Infective endocarditis (IE) is a serious infection of the inner surface of heart, resulting from minor lesions in the endocardium. The damage induces a healing reaction, which leads to recruitment of ...
Oral non-β-lactam antibiotics are commonly used for empirical therapy of Staphylococcus aureus infections, especially in outpatient settings. However, little is known about potential geographic hetero...
To characterize the spatiotemporal trends of resistance to non-β-lactam antibiotics among community-onset S aureus infections, including regional variation in resistance rates and geographical heterog...
This cross-sectional study used data from Veterans Health Administration clinics collected from adult outpatients with S aureus infection in the conterminous 48 states and Washington, DC, from January...
Resistance to lincosamides (clindamycin), tetracyclines, sulfonamides (trimethoprim-sulfamethoxazole [TMP-SMX]), and macrolides....
Spatiotemporal variation of S aureus resistance to these 4 classes of non-β-lactam antibiotics, stratified by methicillin-resistant S aureus (MRSA) and methicillin-sensitive S aureus (MSSA), and subdi...
A total of 382 149 S aureus isolates from 268 214 unique outpatients (mean [SD] age, 63.4 [14.8] years; 252 910 males [94.29%]) were analyzed. There was a decrease in the proportion of MRSA nationwide...
In this study of outpatient S aureus isolates, MRSA became less common over the 10-year period, and MRSA isolates were increasingly resistant to tetracyclines and TMP-SMX. Geographic analysis indicate...
Hispanic people with CF (pwCF) have increased morbidity than non-Hispanic White pwCF, including increased risk of Pseudomonas aeruginosa. We aimed to determine if Staphylococcus aureus (S. aureus) acq...
This longitudinal cohort study of pwCF ages 0-25 years in the CF Foundation Patient Registry compared acquisition of methicillin-sensitive S. aureus (MSSA), methicillin-resistant S. aureus (MRSA), per...
Of 10,640 pwCF, 7.5% were Hispanic and 92.5% were non-Hispanic White. Hispanic pwCF had a 19% higher risk of acquiring MSSA (HR 1.19, 95% CI 1.10-1.28, p<0.001) and 13% higher risk of acquiring MRSA (...
Hispanic pwCF <25 years of age have an increased risk of acquiring MSSA and acquired MSSA and MRSA at an earlier age. Differences in S. aureus acquisition may contribute to increased morbidity in Hisp...
Staphylococcus aureus (S. aureus) is accountable for a wide variety of clinical disease with a high rate of morbidity and mortality around the globe. It has a leading place into the ESKAPE group that ...
Staphylococcus aureus is a significant human pathogen, causing a variety of infections, from skin and soft tissue infections to endocarditis, bone and joint infections and deep tissue abscesses. Morta...
In recent years, optimized dosing of antibiotics is increasingly being recognized as a cornerstone of management for severe infections including S. aureus bacteraemia. This comprehensive review detail...
This review details the different PK/PD targets for drugs used to treat S. aureus bacteraemia and how to apply them in various scenarios. The drug doses that achieve them, and the risks of toxicity ar...
Biofilm-forming Staphylococcus aureus can easily accumulate on various food contact surfaces which induce cross-contamination and are difficult to eliminate in the food industry. This study aimed to e...